Upon completion of this activity, participants will be able to identify lessons from the successful development of the Ebola vaccine ERVEBO® that may inform future vaccine development for outbreak-prone diseases affecting low- and middle-income countries.

Upon completion of this activity, participants will be able to recognize the needs and potential barriers to care for persons with chronic conditions and disabilities to promote appropriate healthcare accommodations and best health outcome.

Upon completion of this activity, participants will be able to understand what are real world data and real world evidence, understand the concept of target trial emulation using real world data and understand why and how AI can help to perform better target trial emulation.

Upon completion of this activity, participants will be able to understand rationale and evidence base for different crystalloid fluid types in pediatric sepsis resuscitation and describe the design and implementation of a large pragmatic trial in pediatric sepsis.

Upon completion of this activity, participants will be able to have knowledge on the management of patients with single ventricle heart disease, recognize the prevalence of the problem and understand the long-term impact of single ventricle congenital heart disease on other organ systems.

Upon completion of this activity, participants will be able to apply a learning health system framework to improve the health of children with rare disease and discuss how PEDSnet infrastructure can enable and accelerate research in rare pediatric disease.

Upon completion of this activity, participants will be able to apply a health equity framework to their research regardless of their research domain, expand parental and family advocacy for health equity and quality improvement and embrace bold innovation to redesign health systems for equity.